CIK: 1120362 - Address: C/o Milestone Pharmaceuticals Inc., 1111 Dr. Frederik-Philips Blvd, Ste 420, Montr?al, A8 H4M 2X6
23 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret214-011426151912
P%wins75257575253351
S%ret11921-8-28-53-83-28
S%wins3344446710010065

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

6/1/22 21:32
5/31/22
MISTMilestone Pharmaceuticals Inc.A8HealthDrugPharmaceutical PreparationsTruex Paul FA8DM.d1161.51077999%82D
6/1/22 21:32
5/31/22
MISTMilestone Pharmaceuticals Inc.A8HealthDrugPharmaceutical PreparationsTruex Paul FA8DP.d285.6005782D
9/7/17 18:56
9/7/17
ANTHAnthera Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsTruex Paul FCADP71.34054217I
9/22/16 19:29
9/20/16
ANTHAnthera Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsTruex Paul FCAOCEOM.d102.0815694M84-65-10227-312-1-19-36-89
7/1/14 20:09
6/30/14
ANTHAnthera Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsTruex Paul FCAOP,CEOM42.0812729M-86-8221123-301-6-14-47-52153
7/2/12 15:53
6/29/12
ANTHAnthera Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsTruex Paul FCADOP,CEOP150.76000203725I-87-92-88-69-65-69-73-773155746-3-26
2/17/12 17:15
2/15/12
ANTHAnthera Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsTruex Paul FCADOP,C.E.O.S-1187.840-15-2705I64381827845-7-8-60-73-87-90
2/2/12 19:37
1/31/12
ANTHAnthera Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsTruex Paul FCADOP,C.E.O.M.d50.26000203682I80142629201463-1-22-78-87-92
1/19/12 17:03
1/17/12
ANTHAnthera Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsTruex Paul FCADOP,Chief S-1016.750-15-2669I38-19192114-331020-72-81-91
12/16/11 21:53
12/15/11
ANTHAnthera Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsTruex Paul FCADOP,CEOS-956.340-15-2683I29-2032-817-2-4-3-35-52-59-90
11/17/11 16:01
11/15/11
ANTHAnthera Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsTruex Paul FCADOP,CEOS-2096.960-30-4698M21-162536-75-5-1-9-321-67-87
10/25/11 21:55
10/21/11
ANTHAnthera Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsTruex Paul FCADOP,CEOS-1456.250-23-3728I73-6604725193-9-156-72-83
10/20/11 21:28
10/18/11
ANTHAnthera Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsTruex Paul FCADOP,CEOS-426.250-7-1751I-5-9-263225751419815-67-83
8/31/11 20:02
8/29/11
TSRXTrius Therapeutics IncDEHealthDrugPharmaceutical PreparationsTruex Paul FCADP146.80021813D670-16-14424-4-3016-21
8/9/11 18:16
8/8/11
ANTHAnthera Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsTruex Paul FCADOP,CEOM.d130.26000507758D654-14-27-25-23-12-18-24-27521-90
7/18/11 17:40
7/15/11
ANTHAnthera Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsTruex Paul FCADOP,CEOS-1197.950-15-2708I956344-1-1-3-231-37-28-13-84
6/17/11 19:50
6/15/11
ANTHAnthera Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsTruex Paul FCADOP,CEOS-1258.300-15-2768M3670382005-1511-38-18-62
5/18/11 19:28
5/16/11
ANTHAnthera Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsTruex Paul FCADOP,CEOS-1077.160-15-2783M1228721511119166-34-13-77
4/14/11 20:35
4/13/11
ANTHAnthera Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsTruex Paul FCADOP,CEOM.d80.26000304807M-21-95-7-18-21-1752233466-66
11/24/10 12:36
11/23/10
TSRXTrius Therapeutics IncDEHealthDrugPharmaceutical PreparationsTruex Paul FCADM.d101.290718911D-14-120860-8359131106
11/24/10 12:36
11/23/10
TSRXTrius Therapeutics IncDEHealthDrugPharmaceutical PreparationsTruex Paul FCADP.d43.50011011D-14-120860-8359131106
4/7/10 14:37
4/7/10
ANTHAnthera Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsTruex Paul FCADOP,CEOM.d30.14000233717D-2-1-121-42-19-40-3
3/2/10 21:07
3/1/10
ANTHAnthera Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsTruex Paul FCADOP,CEOP77.12110664D0-2-4-17-46-24

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact